While cases of zolpidem improving aphasia in people with stroke have been described, use for this purpose has unclear benefit.[63] Zolpidem has also been studied in persistent vegetative states with unclear effect.[64] A 2017 systematic review concluded that while there is preliminary evidence of benefit for treating disorders of movement and consciousness other than insomnia (including Parkinson's disease), more research is needed.[65]